---
figid: PMC3268941__nihms-343880-f0001
figtitle: Canonical Wnt/Beta-catenin and non-canonical Wnt signaling pathways
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Xenopus laevis
- Lareunionomyces loeiensis
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
- Xenopus laevis
pmcid: PMC3268941
filename: nihms-343880-f0001.jpg
figlink: /pmc/articles/PMC3268941/figure/F1/
number: F1
caption: The canonical Wnt/β-catenin and non-canonical Wnt signaling pathways. In
  the Wnt/β-catenin pathway, Wnt ligands form a ternary complex with Fzd and LRP5/6,
  which disrupts the Axin, CK1, GSK3β, and β-catenin complex via the activation of
  Dvl. Subsequently, cytoplasmic β-catenin stability increases which results in the
  formation of the β-catenin/TCF transcriptional complex and the ensuing expression
  of respective target genes. The Wnt/Ca2+ pathway is activated via the interaction
  of Wnt with Fzd and the Ror2 receptors. This interaction recruits Dvl to the plasma
  membrane where it interacts with Fzd and G-proteins to increase intracellular Ca2+
  levels, which activate CamkII, PKC, and NFAK. Activation of these three kinases
  results in the inhibition of Wnt/β-catenin signaling, the induction of tissue separation,
  and the regulation of ventral fate, respectively. In the Wnt/PCP pathway, Wnt interacts
  with Fzd and Ror2 and activates Dvl. Dvl in turn activates Rac1/RhoA, which activate
  JNK and ROCK2, respectively. JNK and ROCK2 are involved in cytoskeletal remodeling.
papertitle: Frizzled7 as an emerging target for cancer therapy.
reftext: Taj D. King, et al. Cell Signal. ;24(4):846-851.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9427407
figid_alias: PMC3268941__F1
figtype: Figure
redirect_from: /figures/PMC3268941__F1
ndex: 6849df2f-deb5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3268941__nihms-343880-f0001.html
  '@type': Dataset
  description: The canonical Wnt/β-catenin and non-canonical Wnt signaling pathways.
    In the Wnt/β-catenin pathway, Wnt ligands form a ternary complex with Fzd and
    LRP5/6, which disrupts the Axin, CK1, GSK3β, and β-catenin complex via the activation
    of Dvl. Subsequently, cytoplasmic β-catenin stability increases which results
    in the formation of the β-catenin/TCF transcriptional complex and the ensuing
    expression of respective target genes. The Wnt/Ca2+ pathway is activated via the
    interaction of Wnt with Fzd and the Ror2 receptors. This interaction recruits
    Dvl to the plasma membrane where it interacts with Fzd and G-proteins to increase
    intracellular Ca2+ levels, which activate CamkII, PKC, and NFAK. Activation of
    these three kinases results in the inhibition of Wnt/β-catenin signaling, the
    induction of tissue separation, and the regulation of ventral fate, respectively.
    In the Wnt/PCP pathway, Wnt interacts with Fzd and Ror2 and activates Dvl. Dvl
    in turn activates Rac1/RhoA, which activate JNK and ROCK2, respectively. JNK and
    ROCK2 are involved in cytoskeletal remodeling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - pcp
  - Bmp1
  - Pgpep1
  - Prcp
  - Ctnnb1
  - Lrp6
  - Lrp5
  - Ror2
  - Rora
  - Dvl1
  - Axin1
  - Rac1
  - Rhoa
  - Mapk8
  - Rock2
  - BMP1
  - PRCP
  - PGPEP1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - LRP6
  - LRP5
  - ROR2
  - RORA
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - AXIN1
  - AXIN2
  - RAC1
  - RNASE1
  - RHOA
  - CAMK1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK8
  - MAPK9
  - MAPK10
  - ROCK2
  - HNF4A
  - Pcp
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - arm
  - arr
  - Nrk
  - fz
  - dsh
  - Axn
  - Rac2
  - Rho1
  - CaMKI
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - bsk
  - Rok
  - pan
  - ctnnb1.S
  - ctnnb1.L
  - lrp6.L
  - lrp6.S
  - lrp5.L
  - ror2.L
  - dvl2.L
  - dvl2.S
  - axin1.S
  - rac3.S
  - rac1.L
  - rhoa.L
  - camk1.S
  - camk1.L
  - camk1d.S
  - mapk8.L
  - mapk8.S
  - rock2.L
  - Cancer
---
